Brinton Pharma to ramp up Favipiravir production
Mumbai: To aid the country's fight against the deadly second wave of Covid-19, Pune-based drugmaker Brinton Pharmaceutical has announced that it will triple the production of the widely demanded drug Favipiravir, marketed under the brand name Faviton 400 at a cost of Rs 790/10 tablets, reports BW Business World.
Considering the current need for widely prescribed covid drugs, the daily added that Brinton Pharmaceutical has also decided to expand the manufacture of additional drugs Scabover & Iverbond (Ivermectin 12 mg) Tablet and Doxybond LB & Briodox (Doxycycline) Tablet, which are widely prescribed in the management of covid 19.
As per the company, Favipiravir production will be enhanced from 15 lakh to 50 lakh units and they will further continue to increase the production of its crucial medicines to help save many lives.
The cost declared by the Brinton pharma is Rs 790/10 tablets where the top-selling Favipiravir brand in April, Glenmark's FabiFlu 400 costs Rs 1224/17 tablet.
The decision to increase the production of critical medications comes at a time when families are unable to secure hospital beds for their loved ones, and more fatalities are occurring as a result of hospitals running out of oxygen.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.